| 2025 | 2024 | 2023 | 2022 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 131,1 k € | +8.5% | 120,8 k € | -25.1% | 161,3 k € | +2.4% | 157,6 k € | -2.8% | 162,2 k € | -3.6% | 168,2 k € | -3.4% | 174,1 k € | +3.4% | 168,3 k € | -1.4% | 170,8 k € | -7.3% | 184,3 k € | +12.5% | 163,8 k € | |
| EBITDA | 51,0 k € | +31.8% | 38,7 k € | -52.5% | 81,5 k € | -18.6% | 100,2 k € | +12.8% | 88,8 k € | +43.2% | 62,0 k € | -14.0% | 72,1 k € | +12.6% | 64,1 k € | -2.7% | 65,9 k € | -28.2% | 91,7 k € | -5.6% | 97,1 k € | |
| Operating profit | 47,1 k € | +34.8% | 34,9 k € | -54.9% | 77,3 k € | +84.1% | 42,0 k € | +30.4% | 32,2 k € | +456.1% | 5,8 k € | -64.5% | 16,3 k € | +57.2% | 10,4 k € | -9.4% | 11,5 k € | -69.2% | 37,3 k € | -14.1% | 43,4 k € | |
| Profit/loss | 35,8 k € | +27.5% | 28,1 k € | -51.1% | 57,5 k € | +85.5% | 31,0 k € | +64.7% | 18,8 k € | +1731.5% | 1,0 k € | -84.1% | 6,5 k € | +387.4% | 1,3 k € | -67.1% | 4,0 k € | -81.9% | 22,3 k € | -12.5% | 25,5 k € | |
| Equity | 182,9 k € | +10.3% | 165,9 k € | 0.0% | 165,9 k € | 0.0% | 165,9 k € | +69.1% | 98,1 k € | +23.8% | 79,3 k € | +1.3% | 78,2 k € | +31.8% | 59,4 k € | +2.3% | 58,1 k € | +7.5% | 54,0 k € | +70.4% | 31,7 k € | |
| Total assets | 313,2 k € | -2.7% | 321,8 k € | +8.0% | 298,0 k € | +17.6% | 253,5 k € | -32.0% | 372,9 k € | -8.3% | 406,7 k € | -7.6% | 440,3 k € | -9.6% | 486,9 k € | -13.9% | 565,2 k € | -9.6% | 625,3 k € | -6.6% | 669,4 k € | |
| Cash | 151,3 k € | +9.0% | 138,9 k € | -3.5% | 144,0 k € | +44.6% | 99,5 k € | +54.1% | 64,6 k € | +6.2% | 60,9 k € | +80.8% | 33,7 k € | +31.5% | 25,6 k € | -58.7% | 61,9 k € | -6.8% | 66,5 k € | -12.1% | 75,6 k € | |
| Debts | 130,4 k € | -16.4% | 155,9 k € | +18.0% | 132,2 k € | +50.8% | 87,7 k € | -68.1% | 274,8 k € | -16.1% | 327,5 k € | -9.6% | 362,1 k € | -15.3% | 427,5 k € | -15.6% | 506,7 k € | -11.2% | 570,8 k € | -10.5% | 637,7 k € | |
| Staff | — | — | — | — | 1,5 | 1,5 | 1,5 | 1,9 | 1,5 | 1,5 | 1,5 | |||||||||||
Private limited company · Ciney · incorporated on 29/03/2012
Private limited company profitable and well capitalised. Cash position rising (+9.0%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
PHARMACIE DU PETIT RY is a Private limited company incorporated in 2012. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Ciney.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette